
Research and development of novel antimicrobials urgently needed

Leqembi’s benefits outweigh risks in a restricted patient population

A new tool to respond rapidly to emerging animal and public health threats

CHMP recommends eight new medicines for approval in the EU

Send us your comments by 30 November 2024

How to improve quality of marketing authorisation application submissions
Find medicine
What's new
FAQs
Latest news
Use of opioid medicines with Mysimba may lead to serious side effects

Leqembi (lecanemab) recommended for treatment of early Alzheimer’s disease

Re-examination concludes that benefits outweigh risks in a restricted patient population

Platform technologies enable rapid response to emerging infectious disease threats
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.

PRAC carried out its broad range of responsibilities for managing the risks associated with medicine use
Events
This walk-in clinic on CTIS functionalities provides an opportunity for sponsors to receive practical information about the Clinical Trials Information System by asking questions to CTIS experts in real time.
This is eleventh quarterly meeting of the Industry Standing Group (ISG).